Evidence map›Paper›PMID 31977878›Full record

ArticleMedicine2020

Effectiveness of a multicomponent treatment versus conventional treatment in patients with fibromyalgia: Study protocol.

Felipe Araya-Quintanilla, Héctor Gutiérrez-Espinoza, María Jesús Muñoz-Yánez, Iván Cavero-Redondo, Celia Álvarez-Bueno, Vicente Martinez-Vizcaíno

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Symptomatology of Fibromyalgia Syndrome in Men: A Mixed-Method Pilot Study.International journal of environmental research and public health · 2022
    Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 4 countries.

Felipe Araya-QuintanillaRehabilitation and Health Research Center. CIRES, Universidad de las Américas.
Héctor Gutiérrez-EspinozaRehabilitation and Health Research Center. CIRES, Universidad de las Américas.
María Jesús Muñoz-YánezRehabilitation and Health Research Center. CIRES, Universidad de las Américas.
Iván Cavero-RedondoUniversidad de Castilla-La Mancha, Health and Social Research Center, Cuenca, Spain.
Celia Álvarez-BuenoUniversidad de Castilla-La Mancha, Health and Social Research Center, Cuenca, Spain.
Vicente Martinez-VizcaínoUniversidad de Castilla-La Mancha, Health and Social Research Center, Cuenca, Spain.
Universidad Politécnica y Artística del Paraguay · PYHospital San Borja Arriarán · CLUniversidad Autónoma de Chile · CLUniversidad SEK · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFibromyalgia (FM) is a chronic pain syndrome characterized by widespread musculoskeletal pain and multiple symptoms. It is a common clinical condition whose etiology is unclear. Currently, there is no gold standard treatment for FM. Management of this condition is therefore aimed at reducing symptoms and maintaining the individual's ability to function optimally. Based on the principal symptoms and characteristics of individuals with FM, we hypothesized that the implementation of a multicomponent treatment (with physical exercise, cognitive behavioral therapy adding to a graded motor imagery program, and therapeutic neuroscience education) would be more effective than conventional treatment in women with FM. This paper describes the rationale and methods of study intended to test the effectiveness of multicomponent treatment versus conventional treatment in patients with FM. METHOD/

designFifty-six female individuals between 18 and 65 years of age, who were referred to the physical therapy department of the Rehabilitar Center in Chile, will be randomized into two treatment arms. The intervention group will receive a multicomponent treatment program for duration of 12 weeks. The control group will receive a conventional treatment for this condition for 12 weeks. The primary outcome measure will be the pain intensity score, measured by the numeric pain rating scale (NPRS), and the secondary outcomes will be the FM Impact Questionnaire (FIQ), and affective components of pain, such as catastrophizing using the Pain Catastrophizing Scale (PCS), fear of movement using the Tampa Scale Kinesiophobia (TSK), and sleep quality as measured by the Pittsburgh Sleep Quality Index (PSQI). DISCUSSION: This paper reports the design of a randomized clinical trial aimed at assessing the effectiveness of the multicomponent treatment versus conventional treatment in women with FM.

trial registrationBrazilian registry of clinical trials UTN number U1111-1232-0862. Registered 22 April 2019.

Indexed as

AdultAgedCatastrophizationCognitive Behavioral TherapyExercise TherapyFemaleFibromyalgiaHumansMiddle AgedPainPain MeasurementRandomized Controlled Trials as TopicYoung Adult

Identifiers

PMID31977878
PMCPMC7004771
OpenAlexW3002467028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.